The role of folate in the prevention of neural tube defects: Human and animal studies

Nutrition Reviews

Volumn 59, Issue 8 II, 2001, Pages S13-S23

  Fleming, A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPTERIN; ANTICONVULSIVE AGENT; BINDING PROTEIN; FLUOROURACIL; FOLIC ACID; FOLIC ACID ANTAGONIST; METHOTREXATE; NITROUS OXIDE; TERATOGENIC AGENT; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; CENTRAL NERVOUS SYSTEM MALFORMATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG SENSITIVITY; EMBRYO; FEMALE; FOLATE METABOLISM; GENE MUTATION; HUMAN; INCIDENCE; MOUSE; MOUSE MUTANT; NEURAL TUBE DEFECT; NEURULATION; NONHUMAN; NUTRITIONAL DEFICIENCY; POPULATION RESEARCH; TERATOGENESIS; VITAMIN SUPPLEMENTATION;

ANIMALIA;

EID: 0034892460     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2001.tb05497.x     Document Type: Conference Paper

References (97)

1. The embryonic development of mammalian neural tube defects
2. Clues to the aetiology of neural tube malformations
3. Female preponderance for hereditary exencephaly in mice also exists in fetuses
4. Neural tube defects and sex ratios
5. A review of the theories of vertebrate neurulation and their relationship to the mechanics of neural tube birth defects
6. Neural tube defects: A review of human and animal studies on the etiology of neural tube defects
7. Etiologic heterogeneity of neural tube defects: Clues from epidemiology
8. Neural tube defects in the Sikhs
9. Doubleblind randomised controlled trial of folate treatment before conception to prevent recurrence of neural tube defects
10. Prevention of neural tube defects: Results of the Medical Research Council vitamin study
11. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation
12. Apparent prevention of neural tube defects by periconceptional vitamin supplementation
13. Folic acid metabolism and mechanisms of neural tube defects
14. Can terathanasia explain the protective effect of folic-acid supplementation on birth defects?
15. Folic acid deficiency and congenital malformation
16. 12 concentrations in pregnancies associated with neural tube defects
17. Maternal vitamin levels during pregnancies producing infants with neural tube defects
18. 12 are independent risk factors for neural tube defects
19. Neural-tube defects and derangement of homocysteine metabolism
20. Homocysteine metabolism in pregnancies complicated by neural-tube defects
21. Methionine synthase and neural tube defects
22. Analysis of select folate pathway genes, PAX3, and human T in a Midwestern neural tube defect population
23. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida
24. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia
25. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
26. A genetic defect in 5,10-methylenetetrahydrofolate reductase in neural tube defects
27. Low blood folates in NTD pregnancies are only partly explained by thermolabile 5,10-methylenetetrahydrofolate reductase: Low folate status alone may be the critical factor
28. Spina bifida, 677T→C mutation, and role of folate
29. Methylenetetrahydrofolate reductase and neural tube defects
30. Relevance to spina bifida of mutated methylenetetrahydrofolate reductase
31. A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects?
32. Waardenburg syndrome and spina bifida
33. Waardenburg syndrome and neural tube defects
34. Possible homozygous Waardenburg syndrome in a fetus with exencephaly
35. The effects of periconceptional folic acid and vitamin supplementation on maternal folate levels and on neurulating hamster embryos in vivo
36. Growth of 9.5-day rat embryos in folic acid-deficient serum
37. Folate deficiency alone does not produce neural tube defects in mice
38. Mechanisms of normal and abnormal neurulation: Evidence from embryo culture studies
39. Changes with gestational age in the nutritional requirements of postimplantation rat embryos in culture
40. Whole rat embryos require methionine for neural tube closure when cultured on cow serum
41. Methionine and iron as growth factors for rat embryos cultured in canine serum
42. Prevention of neural tube defects by and toxicity of Lhomocysteine in cultured postimplantation rat embryos
43. Clinical teratology counseling and consultation case report: Low dose methotrexate exposure in the early weeks of pregnancy
44. Multiple congenital anomalies in a fetus exposed to 5-fluorouracil during the first trimester
45. Incorporation of 5-fluorouracil-2-C-14 by mouse embryos
46. Polygenic control of the teratogenicity of 5-fluorouracil in mice
47. Early events following maternal exposure to 5-fluorouracil lead to dysmorphology in cultured embryonic tissues
48. Teratogen update: Valproic acid
49. Valproic acid-induced neural tube defects
50. Alteration of embryonic folate metabolism by valproic acid during organogenesis: Implications for mechanism of teratogenesis
51. Diurnal variation of folate concentrations in mouse embryo and plasma: The protective effect of folinic acid on valproic acid-induced teratogenicity is time dependent
52. Valproic acid-induced neural tube defects: Reduction by folinic acid in the mouse
53. Lack of attenuation of valproic acid-induced effects by folinic acid in rat embryos in vitro
54. Effects of nitrous oxide on day 9 rat embryos grown in culture
55. Methionine prevents nitrous oxide-induced teratogenicity in rat embryos grown in culture
56. 12 in rats by nitrous oxide
57. Risk of neural tube defect-affected pregnancy is associated with a block in maternal one-carbon metabolism at the level of N-5-methyltetrahydrofolate: Homocysteine methyltransferase
58. Are common mutations of cystathionine beta-synthase involved in the aetiology of neural tube defects?
59. Homocysteine induces congenital defects of the heart and neural tube: Effect of folic acid
60. Arsenate-induced neural tube defects not influenced by constant rate administration of folic acid
61. Heat- and alcohol-induced neural tube defects: Interactions with folate in a golden hamster model
62. In vitro effect of Sadenosyl methionine on ethanol embryopathy in the rat
63. Expression of a new mutation (Axd) causing axial defects in mice correlates with maternal phenotype and age
64. Prenatal folic acid treatment suppresses acrania and meroanencephaly in mice mutant for the Cart 1 homeobox gene
65. A genetic risk factor for mouse neural tube defects: Defining the embryonic basis
66. Maternal methionine supplementation promotes the remediation of axial defects in Axd mouse neural tube mutants
67. Methionine but not folinic acid or vitamin B-12 alters the frequency of neural tube defects in Axd mutant mice
68. Crooked tail (Cd) models human folate-responsive neural tube defects
69. A new crooked tail mutation involving distinctive pleiotropism
70. Characterization of two cDNAs encoding folatebinding proteins from L1210 murine leukemia cells. Increased expression associated with a genomic rearrangement
71. Expression patterns of folate binding proteins one and two in the developing mouse embryo
72. Mice lacking the folic acid-binding protein Folbpl are defective in early embryonic development
73. Splotch (Sp2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3
74. Analysis of the developmental effects of a lethal mutation in the house mouse
75. Spinal ganglia reduction in the splotch-delayed mouse neural tube defect mutant
76. The splotch (Sp1H) and splotch-delayed (Spd) alleles: Differential phenotypic effects on neural crest and limb musculature
77. Rib truncation and fusions in the Sp2H mouse reveal a role for Pax3 in the specification of the ventro-lateral and posterior parts of the somite
78. Embryonic folate metabolism and mouse neural tube defects
79. Methionine metabolism in mammals
80. Pax: Gene regulators in the developing nervous system
81. Developmental control of N-CAM expression by Hox and Pax gene products
82. Pax-3 is necessary for migration but not differentiation of limb muscle precursors in the mouse
83. Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of Myo D
84. Ectopic Pax-3 activates Myo D and Myf-5 expression in embryonic mesoderm and neural tissue
85. Over-expression of the chondroitin sulphate proteoglycan versican is associated with defective neural crest migration in the Pax3 mutant mouse (splotch)
86. Neurofibromin deficiency in mice causes exencephaly and is a modifier for splotch neural tube defects
87. Genetical studies on the skeleton of the mouse. VIII. Curly tail
88. The curly-tail mouse: An experimental model for human neural tube defects
89. Curvature of the caudal region is responsible for failure of neural tube closure in the curly tail (ct) mouse embryo
90. Genesis and prevention of spinal neural tube defects in the curly tail mutant mouse: Involvement of retinoic acid and its nuclear receptors RAR-beta and RAR-gamma
91. A cell type-specific abnormality of cell proliferation in mutant (curly tail) mouse embryos developing spinal neural tube defects
92. Vitamins, folic acid and the cause and prevention of neural tube defects
93. Dietary methionine does not reduce penetrance in curly tail mice but causes a phenotype-specific decrease in embryonic growth
94. Inositol prevents folate-resistant neural tube defects in the mouse
95. Embryonic mechanisms underlying the prevention of neural tube defects by vitamins
96. Incidence of spina bifida occulta in parents and in controls